Mental Health Embracing Psychedelic Therapies

These days, we can make a very strong case for mind-altering treatments for mental health.  Not only is the US FDA supportive of its use, but countless studies from some of the world’s leading companies are showing just how useful it can be. A study from JAMA Psychiatry just found that psilocybin “worked better than … Continue reading “Mental Health Embracing Psychedelic Therapies”

Small-Cap Pharmaceutical Stock Doubles on Positive Data

Never ignore a stock just because it appears to be down-and-out. You may just miss a triple-digit profit opportunity. Look at Axsome Therapeutics (AXSM), for example. Axsome Therapeutics is a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The Company’s product candidates include AXS-05 that is in Phase III … Continue reading “Small-Cap Pharmaceutical Stock Doubles on Positive Data”